2024 Fall Conference | C3 - Neuromuscular Junction Disorders: Myasthenia Gravis, Ocular, and MuSK Myasthenia

Date Friday 10/25/24

Time 09:30 AM - 11:00 AM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Neelam Goyal, MD

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should understand current methods of diagnosis of myasthenia gravis and be able to assess traditional and newer therapies used in myasthenia gravis.

CME Available 1.50 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge, Practice-based Learning and Improvement

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Advanced Practice Provider

Teaching Styles Case-based, Didactic

Program Materials

Event Timeline
09:30 AM - 09:55 AM PDT	Speaker	Acetylcholine Receptor Antibody Positive Myasthenia Gravis Min Kang, MD
09:55 AM - 10:15 AM PDT	Speaker	Ocular and MuSK Myasthenia Gravis Kathie Lin, MD
10:15 AM - 10:35 AM PDT	Speaker	Targeted Therapy in MG: Complement and FcRn Inhibition Neelam Goyal, MD
10:35 AM - 10:50 AM PDT	Speaker	Challenging Cases from Clinical Practice Neelam Goyal, MD, Kathie Lin, MD, Min Kang, MD
10:50 AM - 11:00 AM PDT	Q&A	Questions and Answers Neelam Goyal, MD, Kathie Lin, MD, Min Kang, MD

Faculty Disclosures
Neelam Goyal, MD	Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for UCB. Dr. Goyal has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Janssen. Dr. Goyal has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Alexion. The institution of Dr. Goyal has received research support from Argenx.
Kathie Lin, MD	Dr. Lin has nothing to disclose.
Min Kang, MD	Dr. Kang has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. The institution of Dr. Kang has received research support from UCSF resource allocation program .